UNKNOWN

Uveal Melanoma - Comparative Study

Uveal Melanoma In Sonography and Color Fundus Photos - A Comparative Study

NCT06284512•Medical University of Vienna

Summary

The progress of uveal melanoma is typically monitored with sonography by experienced onco-ophthalmologists. However, there is evidence that twodimensional measurements in color fundus photography match precisely with sonography measurements. This study aims to compare sonography and color fundus photography measurements in order to evaluate the feasibility of monitoring of uveal melanoma with color fundus photography.

Eligibility

Age

18 - 99 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Diagnosis of uveal melanoma

Exclusion Criteria

•Inadequate or missing information on the clinical course in patient charts
•Imaging not feasible due to any reason.

Locations (1)

Medical University of Vienna, Department of Ophthalmology and Optometry

Vienna, Austria

Key Dates

Start Date

October 15, 2023

Primary Completion Date

December 31, 2024

Completion Date

December 31, 2024

Last Updated

February 29, 2024

Enrollment

50

ESTIMATED participants

Conditions

Uveal Melanoma

Interventions

Sonography, color fundus photography

DIAGNOSTIC_TEST

Contacts

Reinhard Told, MD, PhD, Priv.-Doz.

CONTACT

+43 40400 79690 reinhard.told@meduniwien.ac.at

Judith Kreminger, MD

CONTACT

+43 40400 48470 judith.kreminger@meduniwien.ac.at

A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal Melanoma

NCT06007690

Choroidal MelanomaIndeterminate Lesions+2 more

View study

RECRUITINGPHASE2/PHASE3

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

NCT06581406

Metastatic Uveal Melanoma

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 29, 2024Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

RECRUITINGPHASE1